This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hobbie, S. N.
Right arrow Articles by Böttger, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hobbie, S. N.
Right arrow Articles by Böttger, E. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2006, p. 1489-1496, Vol. 50, No. 4
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.4.1489-1496.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Binding of Neomycin-Class Aminoglycoside Antibiotics to Mutant Ribosomes with Alterations in the A Site of 16S rRNA

Sven N. Hobbie,1* Peter Pfister,1 Christian Bruell,1 Peter Sander,1 Boris François,2 Eric Westhof,2 and Erik C. Böttger1

Institut für Medizinische Mikrobiologie, Universität Zürich, CH-8006 Zürich, Switzerland,1 Institut de Biologie Moléculaire et Cellulaire du CNRS, URP Architecture et Réactivité de l'ARN, Université Louis Pasteur, 15 Rue René Descartes, F-67084 Strasbourg Cedex, France2

Received 21 September 2005/ Returned for modification 15 November 2005/ Accepted 17 January 2006

Aminoglycoside antibiotics that bind to the aminoacyl-tRNA site (A site) of the ribosome are composed of a common neamine core in which a glycopyranosyl ring is attached to position 4 of a 2-deoxystreptamine moiety. The core is further substituted by one (ribostamycin), two (neomycin and paromomycin), or three (lividomycin A) additional sugars attached to position 5 of the 2-deoxystreptamine. To study the role of rings III, IV, and V in aminoglycoside binding, we used isogenic Mycobacterium smegmatis {Delta}rrnB mutants carrying homogeneous populations of mutant ribosomes with alterations in the 16S rRNA A site. MICs were determined to investigate drug-ribosome interactions, and the results were compared with that of the previously published crystal structure of paromomycin bound to the ribosomal A site. Our analysis demonstrates that the stacking interaction between ring I and G1491 is largely sequence independent, that rings III and IV each increase the strength of drug binding to the ribosome, that ring IV of the 6'-NH3+ aminoglycosides compensates for loss of interactions between ring II and U1495 and between ring III and G1491, that the aminoglycosides rely on pseudo-base pairing between ring I and A1408 for binding independently of the number of sugar rings attached to the neamine core, that addition of ring V to the 6'-OH 4,5-aminoglycoside paromomycin does not alter the mode of binding, and that alteration of the U1406 · U1495 wobble base pair to the Watson-Crick interaction pair 1406C-1495G yields ribosomal drug susceptibilities to 4,5-aminoglycosides comparable to those seen with the wild-type A site.

* Corresponding author. Mailing address: Institut für Medizinische Mikrobiologie, Universität Zürich, Gloriastr. 30/32, CH-8006 Zürich, Switzerland. Phone: 41-44-634 26 64. Fax: 41-44-634 49 06. E-mail: shobbie{at}immv.unizh.ch.

Antimicrobial Agents and Chemotherapy, April 2006, p. 1489-1496, Vol. 50, No. 4
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.4.1489-1496.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Wang, G., Inaoka, T., Okamoto, S., Ochi, K. (2009). A Novel Insertion Mutation in Streptomyces coelicolor Ribosomal S12 Protein Results in Paromomycin Resistance and Antibiotic Overproduction. Antimicrob. Agents Chemother. 53: 1019-1026 [Abstract] [Full Text]  
  • Hobbie, S. N., Akshay, S., Kalapala, S. K., Bruell, C. M., Shcherbakov, D., Bottger, E. C. (2008). Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity. Proc. Natl. Acad. Sci. USA 105: 20888-20893 [Abstract] [Full Text]  
  • Fan-Minogue, H., Bedwell, D. M. (2008). Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity. RNA 14: 148-157 [Abstract] [Full Text]  
  • Bistue, A. J. C. S., Ha, H., Sarno, R., Don, M., Zorreguieta, A., Tolmasky, M. E. (2007). External Guide Sequences Targeting the aac(6')-Ib mRNA Induce Inhibition of Amikacin Resistance. Antimicrob. Agents Chemother. 51: 1918-1925 [Abstract] [Full Text]  
  • Possoz, C., Newmark, J., Sorto, N., Sherratt, D. J., Tolmasky, M. E. (2007). Sublethal Concentrations of the Aminoglycoside Amikacin Interfere with Cell Division without Affecting Chromosome Dynamics. Antimicrob. Agents Chemother. 51: 252-256 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»